Oncotarget Combating Doxorubicin-Resistant Acute Myeloid Leukemia In this new study, researchers examined the impact of MIA-602 as monotherapy and in combination... read more May 23, 2024
Oncotarget Targeting Pre-Leukemic Cells: New Hope for Preventing Childhood B-ALL Researchers from Universidad Autónoma de Madrid published a new editorial in Oncotarget detailing a... read more March 31, 2023
Oncotarget Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined... read more January 4, 2023
Oncotarget Trending With Impact: Dual Requirement in Stem Cell Leukemia/Lymphoma For the first time, researchers revealed the protein interactome, phospho-proteome and total proteome for the... read more May 12, 2022
Oncotarget New Study: Nanoparticles Target Acute Myeloid Leukemia Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting... read more September 15, 2021
Oncotarget Tomivosertib Versus Acute Myeloid Leukemia In the cover paper chosen for Oncotarget’s Volume 12, Issue 10, researchers investigated the... read more May 12, 2021
Oncotarget Trending with Impact: Acute Myeloid Leukemia and Midostaurin Response Researchers examined midostaurin resistance and sensitivity in a cohort of patients with acute myeloid leukemia.... read more April 22, 2021
Oncotarget Trending with Impact: Targets for Leukemia Learned From Down Syndrome A recent study discovers new potential target mechanisms for leukemia treatments found in a novel... read more October 1, 2020